Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation

A new intravenous formulation was developed and the client wanted to know if Allucent could help evaluate the proposed magnesium amount in the new formulation considering various populations of pregnant women, neonates, infants, pediatric patients, adults, and adults with renal impairments.

Download the full case study below to learn more.

Share this: